300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Medical Device
Sports
Education
Wellness
Automotive
Biotechnology
eSports
Legal
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Venture Capital
Medical
Theatre
Climate
LGBT
Cannabis
Social
Celebrity
Life Science
Food and Beverage
Publishing
Infrastructure
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Beauty
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Fashion
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Europe
Qatar
Bangladesh
Angola
Cyprus
Barbados
Belgium
Jordan
Azerbaijan
Ethiopia
Austria
Bulgaria
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Ecuador
Bolivia
Belize
Algeria
Italy
Hungary
Belarus
Finland
Grenada
Israel
Lithuania
Honduras
Iceland
Liechtenstein
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

EJ Funds

VC Fund

EJ Funds is a VC fund focused on Therapeutics and Biotechnology. EJ Funds was added in 2012.

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries EJ Funds invests in

TherapeuticsBiotechnologyPharmaceutical

Stages EJ Funds invests in

Series ASeries B

Countries EJ Funds invests in

United States

Investment Focus

Industry

  • Therapeutics 1 (50%)
  • Biotechnology 1 (50%)
  • Pharmaceutical 1 (50%)

Stage

  • Series A 1 (50%)
  • Series B 1 (50%)

Investments

CompanyDescriptionRoundLinks
New Haven Pharmaceuticals New Haven Pharmaceuticals
New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications that represent significant market opportunities. The company's novelproduct pipeline employs proprietary, oral, controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience. $11.8M / Series B / Oct 23, 2014
New Haven Pharmaceuticals New Haven Pharmaceuticals
New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications that represent significant market opportunities. The company's novelproduct pipeline employs proprietary, oral, controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience. $6.5M / Series A / Oct 29, 2012

Co-Investors

Connecticut Innovations Connecticut Innovations 2 deals together
Yale University Yale University 2 deals together
Advantage Capital Advantage Capital 1 deal together
Kuzari Group Kuzari Group 1 deal together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Medical Device
Sports
Education
Wellness
Automotive
Biotechnology
eSports
Legal
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Venture Capital
Medical
Theatre
Climate
LGBT
Cannabis
Social
Celebrity
Life Science
Food and Beverage
Publishing
Infrastructure
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Beauty
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Fashion
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Europe
Qatar
Bangladesh
Angola
Cyprus
Barbados
Belgium
Jordan
Azerbaijan
Ethiopia
Austria
Bulgaria
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Ecuador
Bolivia
Belize
Algeria
Italy
Hungary
Belarus
Finland
Grenada
Israel
Lithuania
Honduras
Iceland
Liechtenstein
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does EJ Funds invest in?

EJ Funds invests primarily in Therapeutics, Biotechnology and Pharmaceutical startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did EJ Funds last invest?

The most recent investment recorded for EJ Funds closed in Oct 2014. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
EJ Funds Find emails